https://www.selleckchem.com/products/mk-8245.html
Report of secondary pain outcomes from a prospective, randomized, open-label clinical trial that compared remifentanil and fentanyl on perioperative hyperglycemic response in cardiac surgery. Single institution, tertiary university hospital. The study comprised 116 adult elective cardiac surgical patients. Participants were randomly assigned to receive either intermittent fentanyl boluses (F) or continuous remifentanil infusion (R) intraoperatively. Postoperative pain was evaluated with pain scores every 6 hours for 48 hours. Pain thres
Like
Comment
Share
